James Arthur Bristol Deciphera Pharmaceuticals, Inc. (DCPH) insider trading activity

James Arthur Bristol is of Deciphera Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of DCPH, which is worth approximately $0. The most recent transaction as insider was on Apr 20, 2021, when has been sold 1,700 shares (Common Stock) at a price of $45.6 per share, resulting in proceeds of $77,520. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

James Arthur Bristol Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 20 2021	SELL Open market or private sale	$77,520 $45.6 p/Share	1,700 Reduced 100.0%	0 Common Stock
Apr 20 2021	BUY Exercise of conversion of derivative security	$6,715 $3.95 p/Share	1,700 Added 50.0%	1,700 Common Stock
Apr 19 2021	SELL Open market or private sale	$245,920 $46.4 p/Share	5,300 Reduced 100.0%	0 Common Stock
Apr 19 2021	BUY Exercise of conversion of derivative security	$20,935 $3.95 p/Share	5,300 Added 50.0%	5,300 Common Stock
Apr 12 2021	SELL Open market or private sale	$645,330 $43.9 p/Share	14,700 Reduced 100.0%	0 Common Stock
Apr 12 2021	BUY Exercise of conversion of derivative security	$58,065 $3.95 p/Share	14,700 Added 50.0%	14,700 Common Stock
Jan 15 2021	SELL Open market or private sale	$354,620 $50.66 p/Share	7,000 Reduced 100.0%	0 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$27,650 $3.95 p/Share	7,000 Added 50.0%	7,000 Common Stock
Oct 09 2020	SELL Open market or private sale	$1,281,572 $54.44 p/Share	23,541 Reduced 100.0%	0 Common Stock
Oct 09 2020	BUY Exercise of conversion of derivative security	$44,492 $1.89 p/Share	23,541 Added 50.0%	23,541 Common Stock

Also insider at

ERAS

Erasca, Inc. Healthcare

Director

BTX

Brooklyn ImmunoTherapeutics, Inc. Healthcare

JAB